Migreen kliinilised uuringud osariigis Alabama
5 uuringut haiguse Migreen jaoks otsivad osalejaid osariigis Alabama.
Linnad osariigis Alabama
Ametlik uuringutekst (inglise keeles)
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Rehabilitation and Neurological Services /ID# 270782, Huntsville
VärbamineFaas 3
Vanused 12–17 · Kõik sood · Uuendatud 22. sept 2026 · NCT06810505Responding With Evidence and Access for Childhood Headaches
- University of Alabama at Birmingham Children's of Alabama, Birmingham
Värbamine
Vanused 10–17 · Kõik sood · Uuendatud 21. sept 2026 · NCT05889624Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Rehabilitation & Neurological Services /ID# 229969, Huntsville
- The Center for Clinical Trials - Saraland /ID# 231546, Saraland
VärbamineFaas 3
Vanused 6–17 · Kõik sood · Uuendatud 14. sept 2026 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Central Research Associates, LLC (CRA) dba Flourish Research, Birmingham
- AMR Mobile, Mobile
VärbamineFaas 3
Vanused 18–75 · Kõik sood · Uuendatud 20. aug 2026 · NCT07645924A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
- Flourish - Birmingham, Birmingham
VärbamineFaas 2
Vanused 18–70 · Kõik sood · Uuendatud 19. mai 2026 · NCT06602479Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.